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Abstract
Aims/hypothesis TCF7L2 is a type 2 diabetes susceptibility
gene and downstream effector of canonical wingless-type
MMTV integration site family (WNT) signalling. However, it
is unknown whether this pathway is active in adult pancreatic
islets in vivo, and whether it is regulated in obesity.
Methods We analysed activation of endogenous WNT
signalling in the endocrine pancreas from wild-type and
obese mice (ob/ob) using a reporter transgene (Topgal).
Regulation of WNT signalling was compared using gene
chip experiments from isolated pancreatic islets. Activation
of canonical WNT signalling in pancreatic islets and the
mouse beta cell line MIN6 was measured using immuno-
blotting for cytosolic β-catenin.
Results Endogenous canonical WNT signalling was absent
in the adult endocrine pancreas in both wild-type and obese
mice. We identified WNT4 as an abundant WNT signalling
molecule in adult pancreatic islets that is induced in two
different insulin-resistant mouse models. Increased expres-
sion of WNT4 inhibited canonical WNT signalling in
pancreatic islets and MIN6 cells.
Conclusions/interpretation Canonical WNT signalling is
not active in adult beta cells in vivo. WNT4 provides a
potential mechanism for suppression of canonical WNT
signalling in obese mice.
Keywords β-Catenin .Microarray . ob/ob . Pancreatic
islets . Topgal . Type 2 diabetes .WNT4
Abbreviations
GFP Green fluorescent protein
GSK3β Glycogen synthase kinase-3
LEF Lymphoid enhancer factor
PDX1 Pancreatic and duodenal homeobox 1
TCF T cell factor
WNT Wingless-type MMTV integration site
Introduction
Among common type 2 diabetes risk genes, polymorphisms
in the TCF7L2 gene provide the strongest disease associ-
ation [1]. The gene encodes for transcription factor 7-like-2,
which interacts with β-catenin as a downstream effector of
the WNT signalling pathway. Canonical WNT signalling
involves binding of WNT molecules to cell-surface recep-
tors called frizzled and to co-receptors, the lipoprotein
receptor-related protein. Binding of WNT molecules leads
to inhibition of glycogen synthase kinase-3 (GSK3β),
which results in the stabilisation of cytosolic β-catenin.
Subsequently, β-catenin translocates to the nucleus where it
activates WNT target genes via binding to T cell factor
(TCF)/lymphoid enhancer factor (LEF) promoter elements.
Polymorphisms in TCF7L2 are associated with impaired
insulin secretion [2, 3] suggesting an important role of the
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WNT/β-catenin pathway in pancreatic islets. However, loss-
of-function experiments in animal models have revealed
conflicting results. Transgenic expression of an inhibitor of
WNT signalling (Pdx1-tTa/TRE-axin) revealed a decrease of
pancreatic beta cell mass by 50–60% and impaired glucose
tolerance [4], but attenuation of WNT signalling in a different
transgenic mouse model (Pdx1/Frz8CD) showed normal
glucose tolerance and a relative increase in endocrine cell
numbers compared with exocrine tissue [5]. Furthermore,
beta cell-specific deletion of β-catenin (Pdx1-Cre,Catnblox/lox)
did not alter islet architecture or glucose tolerance at 6 or
12 weeks of age [6, 7], but deletion of β-catenin in pancreatic
islets at later stages of development (RIP-Cre,Catnblox/lox)
induced about 70% perinatal lethality, possibly because of
hypoglycaemia [8].
Clearly, more research is needed to clarify whether WNT
signalling is active in beta cells in vivo [9]. Therefore, we
studied activation of canonical WNT signalling in pancre-
atic islets from adult wild-type and obese mice using a
reporter transgene (Topgal) and analysed regulation of the
WNT/β-catenin signalling pathway at the molecular level
using gene chip experiments.
Methods
Mice All mice were housed as described previously [10].
Principles of laboratory animal care (NIH, revised 1985) were
followed. ob/ob mice (Lep−/−) were purchased from Jackson
Laboratories (Bar Harbor, ME, USA). Topgal mice were
obtained from E. Fuchs (Rockefeller University, New York,
USA). For gene chip studies, age of mice was 9.7±0.2 (n=36)
vs 8.6±0.1 weeks (n=117, p<0.05); random glucose was
12.6±0.7 (n=36) vs 10.0±0.2 mmol/l (n=107, p<0.05); and
random insulin was 4,669.1±1,567.8 (n=10) vs 68.8±
10.3 pmol/l (n=10, p<0.05); all ob/ob vs control, respectively.
Cell culture Mouse beta cell line MIN6 cells were grown as
described earlier [10]. Adenoviruses were generated using
the Rapid Adenovirus Production System (Viraquest, North
Liberty, USA), employing the pVQ-CMV-K-Npa shuttle
vector containing PCR-cloned murine Wnt4 cDNA.
Isolation of pancreatic islets and RT–PCR analysis Pancre-
atic islets were isolated by collagenase digestion and
differential centrifugation as previously described [10].
Total RNA was extracted from double hand-picked islets
using Trizol reagent (Invitrogen, Carlsbad, CA, USA) and
RT–PCR carried out for semiquantitative gene expression
analysis as described earlier [10].
Oligonucleotide microarray analysis Microarray analysis
was performed as previously described using 10 μg total
RNA from isolated islets per chip experiment [11].
Duplicate arrays were performed for the ob/ob group and
controls, respectively, and genes were considered differen-
tially regulated if a significant p value was obtained
according to the Affymetrix software (Santa Clara, CA,
USA) in all of the four possible pair-wise comparisons.
β-Galactosidase staining Pancreases were perfused via the
bile duct with fixing solution (100 mmol/l NaPO4, pH 7.3,
0.2% [vol./vol.] glutaraldehyde, 5 mmol/l EGTA, 2 mmol/
l MgCl2) and immediately placed in ice-cold PBS contain-
ing 10% (wt/vol.) sucrose. Sections of 4 μm were mounted
on slides and fixed for 2 min at room temperature in fixing
solution. After washing, sections were stained overnight in the
dark at 37°C in staining solution (1 mg/ml X-gal [5-bromo-4-
chloro-3-indolyl-β-D-galactoside], 2.1 mg/ml K4Fe
(CN)6·3H2O, 1.64 mg/ml K3Fe(CN)6, 2 mmol/l MgCl2,
0.04% [wt/vol.] deoxycholate, 0.08% [vol./vol.] NP-40,
100 mmol/l NaPO4, pH 7.3).
Western blotting For detection of cytosolic β-catenin,
MIN6 cells or pancreatic islets were harvested in TRIS-
buffered saline (pH 7.5) containing 2 mmol/l dithiothreitol,
2 mmol/l phenylmethylsulfonyl fluoride, 5 mmol/l EDTA
and 10% (vol./vol.) protease cocktail (Roche, Indianapolis,
USA). Cells were lysed by one freeze/thaw cycle and
subjected to ultracentrifugation (100,000g, 90 min, 4°C).
The resulting cytosolic fractions were separated by 10%
(wt/vol.) SDS–PAGE and transferred onto nylon mem-
branes. β-Catenin and GSK3β were visualised using
monoclonal antibodies (anti-β-catenin [Sigma Aldrich, St
Louis, USA], anti-GSK3β [BD Transduction Laboratories,
Lexington, Kentucky, USA]), peroxidase-labelled second
antibodies and enhanced chemiluminescence (PerkinElmer,
Waltham, MA, USA). Anti-WNT4 polyclonal antibodies
and recombinant WNT3A were purchased from R&D
Systems (Minneapolis, USA).
Results
Absence of activated WNT/β-catenin signalling in pancreatic
islets in wild-type and obese mice in vivo To detect canonical
wnt signalling, we used the transgenic reporter mouse
model Topgal, which harbours the LacZ gene under a TCF/
LEF1-responsive promoter element. Endogenous activation
of canonical wnt signalling in these mice results in β-
galactosidase activity in all WNT-responsive cells. Immu-
nohistochemistry demonstrated that marked β-galactosidase
activity was detected in close proximity to islets within
small vessels of the pancreas (Fig. 1a). We crossed the
Topgal transgene into mice that express green fluorescent
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protein (GFP) under the control of the pancreatic and
duodenal homeobox 1 (PDX1) promoter (PDX-GFP) to
label pancreatic beta cells and PDX1-positive duct cells.
However, PDX1-positive cells in pancreatic islets and
pancreatic ducts lack β-galactosidase activity (Fig. 1b, c).
Lack of β-galactosidase activity in pancreatic islets was not
caused by technical constraints, as β-galactosidase was
readily detectable in pancreatic islets from mutant Foxa2
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Fig. 1 Activation of the WNT/β-catenin pathway in small pancreatic
vessels, but not in the endocrine pancreas in vivo. Activation of the
WNT/β-catenin pathway was visualised in cryosections from the
pancreas of 2-month-old Topgal/wild-type (a), Topgal/PDX-GFP (b,
c) or Topgal/ob/ob (d) mice by β-galactosidase staining (upper
panels). Lower panel shows fluorescence from the same sections with
nuclear DAPI staining. Black arrow, β-galactosidase activity in a
small blood vessel. White arrow, PDX-positive duct cell with absent
β-galactosidase activity. du, pancreatic duct; ex, exocrine pancreas; is,
islet; ve, blood vessel
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Fig. 2 Increased expression of Wnt4 in pancreatic islets from insulin-
resistant mice. cDNA from isolated pancreatic islets from control mice
or two different insulin-resistant mouse models (ob/ob, aP2-nSREBP-
1c) was analysed using semiquantitative RT-PCR (a, b). Gapdh was
amplified to demonstrate equal amounts of cDNA. Quantitative
measurements were obtained by densitometry and expressed as fold
change vs control. *p<0.05, **p<0.01 analysed by two-tailed
student’s t test. −RT, without reverse transcriptase. c, d Amount of
WNT4 protein was measured by immunoblotting in whole cell lysates
(50 μg protein or 150 islets, respectively), antibodies against β-
catenin and GSK3β were used as loading controls. Expression of
WNT4 was compared between isolated pancreatic islets and different
adult mouse tissues in wild-type mice (c) and between pancreatic islets
isolated from control or ob/ob mice (d)
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mice [11] that have one inactivated Foxa2 allele by targeted
insertion of the LacZ gene (data not shown). Next, we
crossed the Topgal transgene into obese mice (ob/ob).
Similarly to our observations in wild-type mice, activation
of the WNT/β-catenin pathway was not detected in
pancreatic islets from obese mice (Fig. 1d).
WNT4 is an abundant protein in pancreatic islets and
upregulated in insulin-resistant mouse models To investigate
the molecular basis for the absence of activated WNT
signalling in pancreatic islets in vivo we performed gene chip
experiments. We collected pancreatic islets from ob/ob mice
and control mice (animal characteristics in the Methods). We
found that 169 genes were consistently regulated, 105 genes
were increased and 64 genes were decreased (Electronic
supplementary material [ESM] Table 1). Importantly, we
confirmed downregulation of several genes in obese mice
that are known to be decreased in beta cells during
hyperglycaemia, i.e. Glut2 (also known as Slc2a2), Mafa,
Slp4 (also known as Sytl4) and G3pdh. Two members of the
WNT signalling pathway, WNT4 and frizzled-related pro-
tein, were upregulated in pancreatic islets from obese mice.
We confirmed regulation of Wnt4 by semiquantitative RT–
PCR (Fig. 2b). In addition, Wnt4 expression was also
increased in islets from a different insulin-resistant mouse
model, lipodystrophic mice that lack adipose tissue (aP2-
nSREBP-1c [11]) (Fig. 2c). Western blot analysis of different
adult mouse tissues detected endogenous WNT4 protein only
in pancreatic islets (Fig. 2b). Consistent with the regulation
at the mRNA level, WNT4 protein is more abundant in islets
from obese mice compared with lean controls (Fig. 2d).
Together, these data demonstrate that WNT4 protein is
enriched in pancreatic islets and its expression is increased in
two different insulin-resistant mouse models.
WNT4 is an inhibitor of the canonical WNT signalling
pathway in pancreatic islets WNT members are not
intrinsically canonical or non-canonical, but their signalling
is dictated by the distinct set of receptors within a certain
cell type [12]. To address the impact of WNT4 on the
WNT/β-catenin pathway we overexpressed WNT4 in
isolated pancreatic islets using an adenovirus system. No
stabilisation of β-catenin was noted when WNT4 levels
were increased in pancreatic islets (Fig. 3a). To characterise
the WNT/β-catenin pathway in beta cells in response to
WNT4 in more detail we analysed MIN6 cells. Consistent
with the results obtained in pancreatic islets, adenoviral
WNT4 did not activate the WNT/β-catenin pathway in
MIN6 cells (Fig. 3b). In contrast, WNT4 efficiently
inhibited the stabilisation of cytosolic β-catenin that had
been induced by recombinant WNT3A. This inhibition was
specific for the WNT receptor, since receptor-independent
stabilisation of cytosolic β-catenin by the GSK3β inhibitor
lithium chloride was not altered by Wnt4 (Fig. 3c). These
results demonstrate that WNT4 is an inhibitor of the WNT/
β-catenin pathway in pancreatic islets and beta cells.
Discussion
The major finding of our study is the absence of activated
canonical WNT signalling in adult pancreatic islets in vivo
even in the presence of obesity and hyperinsulinaemia. This
was surprising, since canonical wnt signalling can be
activated by adipocyte-derived WNT signalling molecules
[13] and high insulin levels [14]. Importantly, our study
identifies a potential mechanism for this discrepancy. In
adult mice, WNT4 is an abundant WNT signalling
molecule in pancreatic islets, and it is not detected in
several other adult mouse tissues. In the context of the
pancreatic islet, WNT4 is a specific inhibitor of canonical
wnt signalling and robust upregulation of WNT4 was
observed in pancreatic islets from two different insulin-
resistant mouse models. Thus, WNT4 can provide a
molecular link to prevent cross-talks between pancreatic
islets and adipocyte-derived WNT signalling molecules (e.g.
from adipocytes within the pancreas [13]) and between
pancreatic islets and hyperinsulinaemia. Higher WNT4
expression in insulin-resistant mice might also induce
non-canonical wnt signalling pathways, which, however,
are diverse and poorly defined in mammalian tissues.
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Fig. 3 WNT4 inhibits canonical WNT signalling in pancreatic islets
at the receptor level. Activation of the WNT/β-catenin pathway was
measured by immunoblotting of β-catenin in cytosolic fractions. a
Comparison of cytosolic β-catenin in isolated pancreatic islets after
infection with control virus (Ad-GFP) or virus that overexpresses
WNT4 (Ad-WNT4). b, c Effect of adenoviral WNT4 on activation of
the WNT/β-catenin pathway in MIN6 cells by recombinant WNT3A
(Rec-WNT3A, 30 ng/ml) (b) or lithium chloride (LiCl, 10 mmol/l) (c)
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Previous studies reported different results on the impact
of wnt/β-catenin signalling in beta cells. Deletion of β-
catenin early in development (Pdx1-Cre,Catnblox/lox) did not
show alterations in islet development and normal glucose
tolerance later during adult life [6, 7]. In contrast, deletion
of β-catenin in pancreatic islets at later stages of develop-
ment (RIP-Cre,Catnblox/lox) induced about 70% perinatal
lethality and the surviving mice showed only mild glucose
intolerance later in adulthood [8]. Beta cells might be
specifically susceptible to loss of β-catenin around the time
of birth, which is consistent with activation of endogenous
canonical wnt signalling in the endocrine pancreas of
newborn mice [6]. However, β-catenin signalling in beta
cells might be dispensable later in life since endogenous
wnt signalling is not activated and possibly even actively
suppressed. Genes that are downstream effectors of canon-
ical WNT signalling such as TCF7L2 could impact
pancreatic islets through β-catenin-independent aspects or
at earlier stages of development.
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